Sedation with sevoflurane during 48-hr in ICU

DRUG2 trials

Sponsors

University Hospital, Clermont-Ferrand

Conditions

Acute Kidney InjuryObesity

Phase 2

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients

CompletedNCT02042612

University Hospital, Clermont-FerrandObesity

Start: 2013-10-31End: 2015-02-28Updated: 2016-06-27

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury

University Hospital, Clermont-FerrandAcute Kidney Injury

Start: 2014-01-31End: 2016-03-31Target: 12Updated: 2014-01-23